期刊文献+

Efficacy of Traditional Chinese Medicine in the Treatment of Rash Caused by Epidermal Growth Factor Receptor Inhibitors: A Frequency Statistics and Meta-Analysis

Efficacy of Traditional Chinese Medicine in the Treatment of Rash Caused by Epidermal Growth Factor Receptor Inhibitors: A Frequency Statistics and Meta-Analysis
原文传递
导出
摘要 Objective:The aim of this study is to evaluate the efficacy of Traditional Chinese Medicine(TCM)in the treatment of rash caused by epidermal growth factor receptor inhibitors(EGFRIs).Materials and Methods:Foreign language database(such as Pub Med,Web of Science,Cochrane Library,EMBASE)and Chinese language database(such as China National Knowledge Infrastructure,VIP Database for Chinese Technical Periodicals[VIP],Wangfang,CBM disc)were searched for all trials of TCM in the treatment of rash caused by EGFRIs until January of 2019.We also looked through the references of relevant studies to supplement additional trials.The SPSS 25.0 was used for statistics of TCM with high frequency,and Review Manager 5.3 was used for meta-analysis.Results:A total of 22 studies were included in the study.We selected TCM whose frequency were>3.0%.They were Lonicera japonica(金银花),Licorice Roots Northwest Origin(生甘草),Cortex Dictamni(白鲜皮),Radix Sophorae Flavescentis(苦参),Schizonepeta(荆芥),Saposhnikovia Divaricate(防风).The meta-analysis revealed that the efficacy of TCM in treating EGFRIs-related rash was better than that of Western medicine or none.Conclusions:TCM could significantly relieve rash caused by EGFRIs,which is worth popularizing.Moreover,the mechanism deserves to be further explored. Objective: The aim of this study is to evaluate the efficacy of Traditional Chinese Medicine(TCM) in the treatment of rash caused by epidermal growth factor receptor inhibitors(EGFRIs). Materials and Methods: Foreign language database(such as Pub Med, Web of Science, Cochrane Library, EMBASE) and Chinese language database(such as China National Knowledge Infrastructure, VIP Database for Chinese Technical Periodicals [VIP], Wangfang, CBM disc) were searched for all trials of TCM in the treatment of rash caused by EGFRIs until January of 2019. We also looked through the references of relevant studies to supplement additional trials. The SPSS 25.0 was used for statistics of TCM with high frequency, and Review Manager 5.3 was used for meta-analysis. Results: A total of 22 studies were included in the study. We selected TCM whose frequency were >3.0%. They were Lonicera japonica(金银花), Licorice Roots Northwest Origin(生甘草), Cortex Dictamni(白鲜皮), Radix Sophorae Flavescentis(苦参), Schizonepeta(荆芥), Saposhnikovia Divaricate(防风). The meta-analysis revealed that the efficacy of TCM in treating EGFRIs-related rash was better than that of Western medicine or none. Conclusions: TCM could significantly relieve rash caused by EGFRIs, which is worth popularizing. Moreover, the mechanism deserves to be further explored.
出处 《World Journal of Traditional Chinese Medicine》 2019年第4期269-275,共7页 世界中医药杂志(英文)
关键词 Epidermal growth factor receptor inhibitors META-ANALYSIS RASH Traditional Chinese Medicine Epidermal growth factor receptor inhibitors meta-analysis rash Traditional Chinese Medicine
作者简介 Prof.Hui-Juan Cui,Department of Integrative Oncology,China-Japan Friendship Hospital,Yinghua Dongjie,Hepingli,Beijing 100029,China.E-mail:chjzryhyy@sina.com。
  • 相关文献

参考文献9

二级参考文献67

  • 1曾青,李熳,曹福元,李玲琍,林传友,张静,陈娣,唐君瑞,陈俊,艾波,施静,关新民.电针对佐剂性关节炎大鼠踝关节周围皮肤及皮下组织NK-1受体与IL-1β荧光双标免疫反应性的影响[J].中国组织化学与细胞化学杂志,2004,13(4):464-468. 被引量:5
  • 2楼友根.试论温病方中“角药”的配伍应用[J].河南中医,2005,25(2):64-65. 被引量:11
  • 3吴洪斌.吉非替尼不良反应的临床表现及其处理[J].药物不良反应杂志,2006,8(1):28-30. 被引量:44
  • 4候家玉,方泰惠.中药药理学[M].北京:中国中医药出版社,2007:41-44,53-58,104-106,234-235.
  • 5Harding J,Burtness H.Cetuximab:An epidermal growth factor receptor chemeric human-murine monoclonal antibody[J].Drugs Today(Barc),2005,41(2):107-127.
  • 6David C,Yves H,Salvatore S,et a1.Cetuximab monotherapy and celux-imab plus irinotecan in irinotecan-refractory metastatic colorectal cancer[J].New Engl J Med,2004,351(4):337-345.
  • 7National Cancer Institute-Cancer Therapy Evaluation Program.CT-CAE v3.0[S/OL].(2005-12-29)[2007-06-11]http://ctep.cancer.gov/reporting/ctc-v3.0.htm1.
  • 8卫生部药政局.93版新药(西药)临床研究指导原则[G]:147.
  • 9孙燕,石远凯.临床肿瘤内科手册[M].北京:人民卫生出版社,2011:349.
  • 10李小寒,尚少梅.基础护理学[M].4版.北京:人民卫生出版社.2006.

共引文献96

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部